SARS News and Research

RSS

Vitamin D deficiency persists despite easy access, review suggests need for tailored supplements

Researchers in a study published in the journal Nutrients delve into the pervasive issue of vitamin D deficiency and its link to various health conditions, advocating for precision nutrition and personalized supplementation to enhance vitamin D intake and effectiveness.

17 Apr 2024

Study highlights how age affects nasal cell response to SARS-CoV-2

Researchers reveal age-related differences in nasal epithelial cell responses to SARS-CoV-2, showing variations in cell types and viral dynamics across pediatric, adult, and older adult groups.

16 Apr 2024

Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses

Whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection influences children's asthma risk.

16 Apr 2024

Novel vaccine approach effective against all virus strains

Scientists at UC Riverside have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised.

15 Apr 2024

Antibiotics ineffective for cough treatment in lower respiratory tract infections

Use of antibiotics provided no measurable impact on the severity or duration of coughs even if a bacterial infection was present, finds a large, prospective study of people who sought treatment in U.S. primary or urgent care settings for lower-respiratory tract infections.

15 Apr 2024

Study reveals age-specific differences in nasal cells' response to SARS-CoV-2

Important differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus, could explain why children typically experience milder COVID-19 symptoms, finds a new study led by researchers at UCL and the Wellcome Sanger Institute.

15 Apr 2024

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

Researchers identified how SARS-CoV-2 targets and manipulates specific lung cells, using innovative techniques to trace the virus's impact on the cells' gene expression, revealing insights into early COVID-19 pathogenesis.

14 Apr 2024

SARS-COV-2 infection not linked to increased risk of asthma development in pediatric patients

In the wake of the COVID-19 pandemic, many families worried about the long-term effects posed by the SARS-COV-2 virus.

13 Apr 2024

Cas13d-NCS: A game-changer in RNA virus defense

The rise of RNA viruses like SARS-CoV-2 highlights the need for new ways to fight them. RNA-targeting tools like CRISPR/Cas13 are powerful but inefficient in the cytoplasm of cells, where many RNA viruses replicate.

13 Apr 2024

Study reveals metabolic markers linked to long COVID-19 severity

Long COVID-19, or post-acute sequelae of SARS-CoV-2 infection (PASC), is a global health phenomenon characterized by persistent symptoms following the acute phase of COVID-19.

13 Apr 2024

Novel model provides a comprehensive framework for studying viral epidemiology and evolutionary dynamics

Understanding the mutation and evolution of viruses (such as SARS-CoV-2) is crucial for effective public health management and response.

12 Apr 2024

Annual COVID-19 vaccine proves to be a wise investment for personal health and pocketbook

Study finds that receiving an annual COVID-19 vaccine is clinically and economically beneficial for individuals, regardless of insurance status, offering savings by reducing the likelihood of infection and its associated costs.

11 Apr 2024

Rethinking the germ theory: A balanced take on microbes and disease outcomes

Review explores the complexities of infectious disease outcomes through a balanced perspective, emphasizing the interplay between pathogenic microbes and host conditions, challenging the traditional germ-disease theory by proposing a more integrated view that considers both pathogen virulence and host immunity's impact on disease manifestation.

10 Apr 2024

Study reveals unexpected vulnerability of lung immune cells to SARS-CoV-2

The lung-cell type that's most susceptible to infection by SARS-CoV-2, the virus that causes COVID-19, is not the one previously assumed to be most vulnerable.

10 Apr 2024

COVID-19 survivors face lingering health challenges

UC San Francisco researchers examined COVID-19 patients across the United States who survived some of the longest and most harrowing battles with the virus and found that about two-thirds still had physical, psychiatric, and cognitive problems for up to a year later.

10 Apr 2024

Study reveals inflammation's role in long COVID's lingering effects

Large-scale study found that long COVID patients exhibit sustained inflammation and specific immune responses associated with varying symptoms, highlighting the importance of personalized treatment approaches.

9 Apr 2024

Nirmatrelvir fails to shorten COVID-19 symptoms in latest trial

A study in The New England Journal of Medicine evaluates the combination of nirmatrelvir and ritonavir against COVID-19, finding it does not significantly reduce symptom duration in vaccinated or unvaccinated adult outpatients.

8 Apr 2024

Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance

Study introduces Reverse Vaccine Development as a strategic approach to identify correlates of protection early in vaccine development against antimicrobial-resistant pathogens, aiming to mitigate risks such as significant phase-III clinical trial failures.

7 Apr 2024

Novel SARS-CoV-2 mutations found in floodwaters near homeless communities

Study highlights the detection of SARS-CoV-2 RNA and novel spike gene mutations in flood control channels affected by homeless populations, demonstrating the value of environmental surveillance in understanding public health dynamics.

4 Apr 2024

Wastewater surveillance reveals COVID-19 transmission patterns in unsheltered encampments

To better understand COVID-19's spread during the pandemic, public health officials expanded wastewater surveillance.

3 Apr 2024

SARS News and Research

Vitamin D deficiency persists despite easy access, review suggests need for tailored supplements

Study highlights how age affects nasal cell response to SARS-CoV-2

Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses

Novel vaccine approach effective against all virus strains

Antibiotics ineffective for cough treatment in lower respiratory tract infections

Study reveals age-specific differences in nasal cells' response to SARS-CoV-2

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

SARS-COV-2 infection not linked to increased risk of asthma development in pediatric patients

Cas13d-NCS: A game-changer in RNA virus defense

Study reveals metabolic markers linked to long COVID-19 severity

Novel model provides a comprehensive framework for studying viral epidemiology and evolutionary dynamics

Annual COVID-19 vaccine proves to be a wise investment for personal health and pocketbook

Rethinking the germ theory: A balanced take on microbes and disease outcomes

Study reveals unexpected vulnerability of lung immune cells to SARS-CoV-2

COVID-19 survivors face lingering health challenges

Study reveals inflammation's role in long COVID's lingering effects

Nirmatrelvir fails to shorten COVID-19 symptoms in latest trial

Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance

Novel SARS-CoV-2 mutations found in floodwaters near homeless communities

Wastewater surveillance reveals COVID-19 transmission patterns in unsheltered encampments

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News